AU7457791A - Stereochemically controlled immobilization of active molecules - Google Patents

Stereochemically controlled immobilization of active molecules

Info

Publication number
AU7457791A
AU7457791A AU74577/91A AU7457791A AU7457791A AU 7457791 A AU7457791 A AU 7457791A AU 74577/91 A AU74577/91 A AU 74577/91A AU 7457791 A AU7457791 A AU 7457791A AU 7457791 A AU7457791 A AU 7457791A
Authority
AU
Australia
Prior art keywords
active molecules
stereochemically controlled
controlled immobilization
immobilization
stereochemically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU74577/91A
Inventor
Willfried Schramm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioquant Inc
Original Assignee
Bioquant Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioquant Inc filed Critical Bioquant Inc
Publication of AU7457791A publication Critical patent/AU7457791A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
AU74577/91A 1990-02-23 1991-02-19 Stereochemically controlled immobilization of active molecules Abandoned AU7457791A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48438190A 1990-02-23 1990-02-23
US484381 1990-02-23

Publications (1)

Publication Number Publication Date
AU7457791A true AU7457791A (en) 1991-09-18

Family

ID=23923931

Family Applications (1)

Application Number Title Priority Date Filing Date
AU74577/91A Abandoned AU7457791A (en) 1990-02-23 1991-02-19 Stereochemically controlled immobilization of active molecules

Country Status (2)

Country Link
AU (1) AU7457791A (en)
WO (1) WO1991013358A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2098960C (en) * 1992-07-10 2004-11-02 Richard Barner Bio specifically recognizing surfaces on solid supports and method for their preparation
WO2011074965A1 (en) * 2009-12-17 2011-06-23 Stichting Sanquin Bloedvoorziening Methods and means for counteracting an activity of an fc domain

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464468A (en) * 1968-03-29 1984-08-07 Agence Nationale De Valorisation De La Recherche (Anvar) Immobilization of active protein by cross-linking to inactive protein
CA1083508A (en) * 1975-11-13 1980-08-12 Jacques Grange Supports having lateral chains, process for obtaining such supports, process for the fixation of organic compounds comprising a glucidic residue on said supports, products and reactives from said chimical fixation
US5011771A (en) * 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
IL75828A (en) * 1985-07-17 1991-06-10 Univ Ramot Immobilization by biologically active proteins

Also Published As

Publication number Publication date
WO1991013358A1 (en) 1991-09-05

Similar Documents

Publication Publication Date Title
AU3478289A (en) Treatment of fibrous materials
AU4171789A (en) Treatment of aqueous systems
AU594805B2 (en) Means for the application of transdermally absorbable active susbstances
AU1676588A (en) Treatment of materials
AU6797094A (en) Cosmetic treatment of substrates
AU8290091A (en) Electrophoresis-based sequencing of oligosaccharides
AU1573588A (en) Medical application for heparin and related molecules
AU6801694A (en) The treatment of small animals
AU1834188A (en) Novel medicated dressings
AU1115095A (en) Treatment of cellulose
AU3509989A (en) Process for the manufacture of optically active naphthothiazepinones
AU5758594A (en) Treatment of viral infections
AU1097192A (en) Treatment of particulate material
AU6660090A (en) Treatment of depression
AU7468894A (en) Process for the enzymatic preparation of optically active n-substituted-3-pyrrolidinol
AU3553489A (en) Novel compounds and treatment
AU6927894A (en) 4-amidinophenylsulphonamides for the treatment of thrombo-embolitic conditions
AU6186490A (en) Treatment of fibrous materials
AU7457791A (en) Stereochemically controlled immobilization of active molecules
AU8185491A (en) Treatment of disease
AU660438B2 (en) Immobilized D-amino acid oxidase and its use for the preparation of medicaments
AU6527390A (en) Pharmaceutical compositions for the treatment of ataxy and equilibrium problems
AU8879691A (en) Treatment of dispersions
AU5538794A (en) Biologically active compounds and process therefor
AU6357890A (en) Expression of alpha-macroglobulins